IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Adial Pharmaceuticals Inc

CUSIP: 00688A114 | 7 institutional holders

Quarters

Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2023

Ameriprise Financial Inc35,000
0.0% of portfolio›$200
Wolverine Asset Management LLC15,606
0.0% of portfolio›$88
Wells Fargo & Company15,000
0.0% of portfolio›$86
GTS Securities LLC14,401
0.0% of portfolio›$86
UBS Group AG6,534
0.0% of portfolio›$39
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Ameriprise Financial Inc
35,000$2000.0%CoreMediumMinneapolis, MN2023-08-14
Wolverine Asset Management LLC
15,606$880.0%Deep ValueVery HighChicago, IL2023-08-07
Wells Fargo & Company
15,000$860.0%CoreLowSan Francisco, CA2023-08-15
GTS Securities LLC
14,401$860.0%ETFVery HighNew York, NY2023-08-16
UBS Group AG
6,534$390.0%CoreMediumZurich, Switzerland2023-08-11
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2023-08-10